Xtant Medical Holdings, Inc. has completed the sale of certain businesses to Companion Spine for approximately $19.2 million, consisting of $11.0 million in cash and $8.2 million in short-term seller financing through an unsecured promissory note maturing on January 15, 2026. The operating contributions of the divested assets and entities will be included in Xtant's results through their December 1, 2025 date of sale. Xtant plans to use the net proceeds from the transaction to reduce long-term debt and enhance cash liquidity. The company stated that this move will allow it to focus on its core biologics business and continue operations without the need for additional external capital.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtant Medical Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA36445) on December 01, 2025, and is solely responsible for the information contained therein.